Powerful insights to help personalize treatment


This test is designed to help identify appropriate targeted therapies and clinical trials. The Solid Tumor Panel tests for clinically significant mutations in solid tumor cancers, including




20+ genes found in
15+ guidelines
for solid tumor genetic testing
115+ genes included in
800+ clinical trials
15+ genes associated with
30+ targeted therapies
that are approved by the FDA